Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease...

Area of Science:

• Genetics
• Biochemistry
• Molecular Biology

Background:

• Mucopolysaccharidoses (MPS) are rare genetic lysosomal storage diseases.
• Defective glycosaminoglycan (GAG) degradation leads to cellular dysfunction.
• MPS subtypes exhibit varied clinical severity, particularly within MPS III and IV.

Purpose of the Study:

• To investigate gene expression patterns across MPS III and IV subtypes.
• To identify molecular differences contributing to disease variability.
• To elucidate the genetic basis for differing clinical courses in MPS III.

Main Methods:

• Transcriptomic analysis of dermal fibroblasts from patients with MPS III and IV subtypes.
• Differential gene expression profiling.
• Analysis of altered transcripts related to cellular pathways.

Main Results:

• Significant variations in gene expression patterns were observed between MPS III subtypes, but not MPS IV.
• Altered transcripts in MPS III subtypes were primarily associated with connective tissue structure (e.g., COL4A1, COL4A2, COMP) and ribosome biogenesis (e.g., RPL10, RPL23, RPLP2).
• These findings highlight molecular distinctions underlying the clinical heterogeneity of MPS III.

Conclusions:

• Genetic factors play a crucial role in the diversified clinical course of MPS III subtypes.
• Distinct gene expression profiles in MPS III subtypes contribute to disease variability.
• Further research into these genetic differences could inform targeted therapeutic strategies.